Meg Jardine's Publications

About Meg Jardine's Publications

Honorary Professorial Fellow, The George Institute for Global Health
  • Associate Professor, Faculty of Medicine, UNSW Sydney

  • Kidney Health Australia - Caring for Australasians with Renal Impairment guideline recommendations for infection control for haemodialysis units

    Nephrology Date published:

  • Physical component quality of life reflects the impact of time and moderate chronic kidney disease, unlike SF-6D utility and mental component SF-36 quality of life: An AusDiab analysis

    Nephrology Date published:

  • Effects of intravenous hydration on risk of contrast induced nephropathy and in-hospital mortality in STEMI patients undergoing primary percutaneous coronary intervention: a systematic review and meta-analysis of randomized controlled trials

    BMC Cardiovascular Disorders Date published:

  • The impact of progressive chronic kidney disease on health-related quality-of-life: a 12-year community cohort study

    Quality of Life Research Date published:

  • Effect of extended hours dialysis on sleep quality in a randomized trial

    Nephrology Date published:

  • Cardiovascular adaptations associated with exercise in patients on hemodialysis

    Seminars in Dialysis Date published:

  • Hyperkalemia and renin-angiotensin aldosterone system inhibitor therapy in chronic kidney disease: A general practice-based, observational study

    PLOS ONE Date published:

  • Effect of SGLT2 inhibitors on cardiovascular, renal and safety outcomes in patients with type 2 diabetes mellitus and chronic kidney disease: A systematic review and meta-analysis

    Diabetes, Obesity and Metabolism Date published:

  • Burden of Care and Quality of Life Among Caregivers for Adults Receiving Maintenance Dialysis: A Systematic Review

    American Journal of Kidney Diseases Date published:

  • Can we IMPROVE cardiovascular outcomes through phosphate lowering in CKD? Rationale and protocol for the IMpact of Phosphate Reduction On Vascular End-points in Chronic Kidney Disease (IMPROVE-CKD) study

    BMJ Open Date published:

  • Canagliflozin Reduces Cardiovascular and Renal Events in Patients With Type 2 Diabetes and Chronic Kidney Disease Regardless of Baseline HbA1c, Including Those With HbA1c < 7%: Results From the CREDENCE Trial

    Date published:

  • Protocol for the Study of Heart and Renal Protection-Extended Review: Additional 5-Year Follow-up of the Australian, New Zealand, and Malaysian SHARP Cohort

    Canadian Journal of Kidney Health and Disease Date published:

  • Cultivating Innovative Pragmatic Cluster-Randomized Registry Trials Embedded in Hemodialysis Care: Workshop Proceedings From 2018

    Canadian Journal of Kidney Health and Disease Date published:

  • Benefits and harms of oral anticoagulant therapy in chronic kidney disease: a systematic review and meta-analysis

    Annals of Internal Medicine Date published:

  • Randomised controlled trial of the impact of haemodiafiltration on uraemic neuropathy: FINESSE study protocol

    BMJ Open Date published:

  • Implementing core outcomes in kidney disease: report of the Standardized Outcomes in Nephrology (SONG) implementation workshop

    Kidney International Date published: